| Literature DB >> 24369888 |
Ling-Wei Wang1, Yi-Wei Chen2, Ching-Yin Ho3, Yen-Wan Hsueh Liu4, Fong-In Chou5, Yuan-Hao Liu6, Hong-Ming Liu6, Jinn-Jer Peir6, Shiang-Huei Jiang4, Chi-Wei Chang7, Ching-Sheng Liu8, Shyh-Jen Wang7, Pen-Yuan Chu3, Sang-Hue Yen2.
Abstract
To introduce our experience of treating locally and regionally recurrent head and neck cancer patients with BNCT at Tsing Hua Open-Pool Reactor in Taiwan, 12 patients (M/F=10/2, median age 55.5 Y/O) were enrolled and 11 received two fractions of treatment. Fractionated BNCT at 30-day interval with adaptive planning according to changed T/N ratios was feasible, effective and safe for selected recurrent head and neck cancer in this trial.Entities:
Keywords: Boron neutron capture therapy; Boronophenylalanine; Head and neck cancer; PET scan
Mesh:
Year: 2013 PMID: 24369888 DOI: 10.1016/j.apradiso.2013.11.134
Source DB: PubMed Journal: Appl Radiat Isot ISSN: 0969-8043 Impact factor: 1.513